Abstract
The mixed-function-oxidase (MFO) activities, ethoxyresorufin and pentoxyphenoxazone O-dealkylase, of cultured Hooded-Lister(HL)-rat hepatocytes declined rapidly during 72 h of culture, whereas in Sprague-Dawley(SD)-rat hepatocytes the MFO activities increased between 24 and 72 h in culture. Cytochrome P-450 content declined at the same rate in both HL- and SD-rat hepatocyte cultures. NADPH:cytochrome c reductase and NADH:cytochrome b5 reductase were more stable in SD- than in HL-rat hepatocyte cultures. 16,16-Dimethylprostaglandins E2 and F2 alpha improved the maintenance of cytochrome P-450 content, MFO activity and NADPH:cytochrome c reductase in the HL-rat hepatocyte cultures. In SD-rat hepatocytes, the prostaglandins had no effect on cytochrome P-450 content or NADPH:cytochrome c reductase activity, whereas they prevented the increase observed in MFO activities between 24 and 72 h after culture.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Burke M. D., Mayer R. T. Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism and cytochrome P-450-binding of phenoxazone and a homologous series of its n-alkyl ethers (alkoxyresorufins). Chem Biol Interact. 1983 Jul 15;45(2):243–258. doi: 10.1016/0009-2797(83)90072-8. [DOI] [PubMed] [Google Scholar]
- Burke M. D., Thompson S., Elcombe C. R., Halpert J., Haaparanta T., Mayer R. T. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol. 1985 Sep 15;34(18):3337–3345. doi: 10.1016/0006-2952(85)90355-7. [DOI] [PubMed] [Google Scholar]
- Dickins M., Peterson R. E. Effects of a hormone-supplemented medium on cytochrome P-450 content and mono-oxygenase activities of rat hepatocytes in primary culture. Biochem Pharmacol. 1980 May 1;29(9):1231–1238. doi: 10.1016/0006-2952(80)90279-8. [DOI] [PubMed] [Google Scholar]
- Falzon M., Milton A. S., Burke M. D. Are the decreases in hepatic cytochrome P-450 and other drug-metabolising enzymes caused by indomethacin in vivo mediated by intestinal bacterial endotoxins? 16,16-Dimethylprostaglandin F2 alpha prevents decreases in hepatic drug-metabolising enzymes due to exogenous endotoxin. Biochem Pharmacol. 1984 Apr 15;33(8):1285–1292. doi: 10.1016/0006-2952(84)90182-5. [DOI] [PubMed] [Google Scholar]
- Funck-Brentano C., Tinel M., Degott C., Letteron P., Babany G., Pessayre D. Protective effect of 16,16-dimethyl prostaglandin E2 on the hepatotoxicity of bromobenzene in mice. Biochem Pharmacol. 1984 Jan 1;33(1):89–96. doi: 10.1016/0006-2952(84)90374-5. [DOI] [PubMed] [Google Scholar]
- Grant M. H., Hawksworth G. M. The activity of UDP-glucuronyltransferase, sulphotransferase and glutathione-S-transferase in primary cultures of rat hepatocytes. Biochem Pharmacol. 1986 Sep 1;35(17):2979–2982. doi: 10.1016/0006-2952(86)90498-3. [DOI] [PubMed] [Google Scholar]
- Grant M. H., Melvin M. A., Shaw P., Melvin W. T., Burke M. D. Studies on the maintenance of cytochromes P-450 and b5, monooxygenases and cytochrome reductases in primary cultures of rat hepatocytes. FEBS Lett. 1985 Oct 7;190(1):99–103. doi: 10.1016/0014-5793(85)80436-1. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Lake B. G., Paine A. J. The effect of hepatocyte culture conditions on cytochrome P-450 linked drug metabolising enzymes. Biochem Pharmacol. 1982 Jun 1;31(11):2141–2144. doi: 10.1016/0006-2952(82)90438-5. [DOI] [PubMed] [Google Scholar]
- Maslansky C. J., Williams G. M. Primary cultures and the levels of cytochrome P450 in hepatocytes from mouse, rat, hamster, and rabbit liver. In Vitro. 1982 Aug;18(8):683–693. doi: 10.1007/BF02796423. [DOI] [PubMed] [Google Scholar]
- Moldéus P., Högberg J., Orrenius S. Isolation and use of liver cells. Methods Enzymol. 1978;52:60–71. doi: 10.1016/s0076-6879(78)52006-5. [DOI] [PubMed] [Google Scholar]
- Morrison H., Hammarskiöld V., Jernström B. Status of reduced glutathione in primary cultures of rat hepatocytes and the effect on conjugation of benzo[a]pyrene-7,8-dihydrodiol-9,10-oxide. Chem Biol Interact. 1983 Jul 15;45(2):235–242. doi: 10.1016/0009-2797(83)90071-6. [DOI] [PubMed] [Google Scholar]
- OMURA T., SATO R. THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. II. SOLUBILIZATION, PURIFICATION, AND PROPERTIES. J Biol Chem. 1964 Jul;239:2379–2385. [PubMed] [Google Scholar]
- Robert A. Current history of cytoprotection. Prostaglandins. 1981;21 (Suppl):89–96. doi: 10.1016/0090-6980(81)90123-4. [DOI] [PubMed] [Google Scholar]
- Sirica A. E., Pitot H. C. Drug metabolism and effects of carcinogens in cultured hepatic cells. Pharmacol Rev. 1979 Sep;31(3):205–228. [PubMed] [Google Scholar]
- Stachura J., Tarnawski A., Ivey K. J., Mach T., Bogdal J., Szczudrawa J., klimczyk B. Prostaglandin protection of carbon tetrachloride-induced liver cell necrosis in the rat. Gastroenterology. 1981 Aug;81(2):211–217. [PubMed] [Google Scholar]
- Steward A. R., Dannan G. A., Guzelian P. S., Guengerich F. P. Changes in the concentration of seven forms of cytochrome P-450 in primary cultures of adult rat hepatocytes. Mol Pharmacol. 1985 Jan;27(1):125–132. [PubMed] [Google Scholar]
- Williams G. M., Laspia M. F., Dunkel V. C. Reliability of the hepatocyte primary culture/DNA repair test in testing of coded carcinogens and noncarcinogens. Mutat Res. 1982 Oct;97(5):359–370. doi: 10.1016/0165-1161(82)90003-6. [DOI] [PubMed] [Google Scholar]
